Genomic Valley Biotech reports standalone nil net profit/loss in the September 2025 quarter
Sales decline 57.14% to Rs 0.09 crore
Genomic Valley Biotech reported no net profit/loss in the quarter ended September 2025 as against net profit of Rs 0.15 crore during the previous quarter ended September 2024. Sales declined 57.14% to Rs 0.09 crore in the quarter ended September 2025 as against Rs 0.21 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var.Sales0.090.21 -57 OPM %066.67 -PBDT00.15 -100 PBT00.15 -100 NP00.15 -100Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Oct 15 2025 | 6:01 PM IST